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ABstR Act
Purpose  Controlled attenuation parameter (CAP) is a non-
invasive method to assess the presence of liver steatosis. It has 
been evaluated in children and adults, mainly in either the obe-
se or in subjects with suspected liver disease. Our aim was to 
describe CAP in healthy non-obese subjects without suspected 
liver steatosis and to suggest cutoff levels for steatosis.
Materials and Methods  We prospectively recruited 187 indi-
viduals aged 8–70 years. All underwent clinical examination, 
including height and weight measurement. Body mass index 
(BMI) was calculated and converted into z-scores. To exclude 
liver pathology, B-mode ultrasound and liver stiffness measu-
rements were performed in all prior to CAP measurement. 
Blood was drawn for liver biochemistry in adults.
Results  CAP was associated with BMI z-score across all ages. 
CAP started to rise alongside BMI z-score already in subjects 
with a BMI below average. CAP values were higher in adults 
than in children (p < 0.001), and higher in adult males than 
adult females (p = 0.014). CAP did not correlate with age within 
the adult or pediatric cohorts. CAP was highly correlated with 
the fatty liver index. 18 and 23 % of subjects showed CAP 
above the suggested cutoff value for children and adults, 
respectively.
Conclusion  CAP was correlated with BMI z-score, even in in-
dividuals with a below-average BMI . We found CAP above pu-
blished cutoff values in a substantial proportion of presumab-
ly healthy, non-obese children and adults, warranting further 
research to clarify whether this represents non-obese non-al-
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Introduction
Non-alcoholic fatty liver disease (NAFLD) has a high impact on the 
global health burden, with a prevalence of 25 % [1]. Although com-
monly associated with obese adults, it is the most prevalent liver 
disease in children [2]. Even in lean adolescents, the prevalence is 
estimated to be 8 % [3]. In adults, non-obese and lean NAFLD is as-
sociated with increased mortality [4].
The criterion standard for diagnosis of NAFLD is liver biopsy. It 
is often performed in children to stage the severity and to elimina-
te other liver diseases [2], but its use is more limited in adults [5]. 
NAFLD can potentially cause fibrosis and cirrhosis, and ultimately 
chronic liver failure necessitating liver transplantation. Thus, non-
invasive monitoring is warranted. Conventional ultrasound (US) ex-
amination is applied in both diagnosis and follow-up, with a global 
sensitivity and specificity of 0.85 and 0.94, respectively, but it is 
not recommended due to poor performance in cases of mild stea-
tosis (i. e., involving 5–33 % of hepatocytes) [2, 5, 6].
Ultrasound attenuates as the US waves penetrate tissue. To com-
pensate for this, the time-gain compensation function is used to 
amplify reflections from deeper locations to obtain a more even B-
mode image. The attenuation increases with increasing fat content 
in the liver tissue. The measurement of attenuation at different 
scanning depths and in different organs, e. g., using the hepato-re-
nal index for assessing fatty liver in NAFLD patients, has been de-
scribed and used to identify and quantify liver steatosis [7].
The controlled attenuation parameter (CAP), implemented in 
the Fibroscan® system, uses this attenuation within liver tissue to 
calculate the CAP, simultaneously measuring liver stiffness. CAP 
has been shown to correlate with the histopathological degree of 
liver steatosis in adults [8, 9] and children [10], with a pooled sen-
sitivity and specificity for mild steatosis of 0.87 and 0.91, respec-
tively [11]. On this basis, adult guidelines suggest that CAP is a pro-
mising tool but state that there is a need for more information [5]. 
Different cutoff values have been suggested for the diagnosis of 
NAFLD: for adults 248 dB/m [9] and in children 225 dB/m [10]. Re-
liability criteria for CAP measurements are not established, but both 
the interquartile range (IQR) (e. g., < 0.4) and IQR divided by the me-
dian (IQR/M) (e. g., < 0.1, < 0.2, or < 0.3) have been proposed [12, 13].
There is a lack of studies in pediatric and combined adult and 
pediatric populations, particularly in subjects without obesity or 
suspected liver disease. We aimed to explore CAP in healthy non-
obese children and adults to establish normal CAP values, with si-
multaneous examination with B-mode ultrasound and liver stiff-
ness measurements. The study was part of a previously published 




The study was performed at a single university hospital from Au-
gust 2017 to January 2018. We prospectively recruited children 
aged 8–17 years and adults aged 25–70 years. All examinations 
were performed by one of two operators experienced in liver stiff-
ness measurements and certified Fibroscan users. Inclusion crite-
ria consisted of valid CAP and LSM using Fibroscan, no history of 
liver disease or any chronic disease with the potential of affecting 
the liver, and lack of obesity defined as an international obesity task 
force (IOTF) grade 2. A total of 87 children and 100 adults were re-
cruited. Height, weight, waist circumference, and body mass index 
(BMI) were recorded and converted into z-scores (standard score; 
standard deviations below or above the mean). BMI z-score was 
used in analyses in children and in the entire cohort, while BMI was 
used in analyses with adults. Blood was drawn for liver biochemistry 
analyses in all adults but not in children. Fatty liver index, non-al-
coholic fatty liver disease (NAFLD) fibrosis scores, and Fib-4, a com-
monly used noninvasive liver fibrosis score, were calculated for all 
adults using published algorithms [16–18]. Subjects with abnor-
mal liver function tests or B-mode signs of steatosis or splenome-
galy were excluded.
B-mode ultrasound evaluation
All participants underwent B-mode ultrasound evaluation using a 
standardized protocol, including evaluation of the liver, gall blad-
der, spleen, and kidneys prior to elastography and CAP measure-
ments. The distance between the skin and the liver capsule was re-
corded.
Liver stiffness measurements (LSM)
Elastography and CAP measurements were performed according 
to the protocol, with subjects in a supine position with the right 
hand resting under their head, after  ≥ 3 hours of fasting. All parti-
cipants were examined using transient elastography (TE, Fibroscan 
with an M-probe), point shear wave elastography (pSWE; in 
Samsung RS80A with the CA1–7A convex array probe), and two-
dimensional shear wave elastography (2D-SWE; in children: GE 
Logiq E9, in adults: GE Logiq S8; both with the C1–6 convex array 
probe). A valid LSM was defined as the median value of 10 acquisi-
tions, given an interquartile range divided by the median (IQR/M) 
of  ≤ 30 %. CAP values were accepted if the LSM by Fibroscan mea-
surement was considered valid.
Controlled attenuation parameter
Controlled attenuation parameter (CAP) was reported in dB/m, 
using the median of 10 acquisitions. The interquartile range (IQR) 
was registered for all measurements.
Statistical analysis
We used SPSS version 25 (SPSS Inc, 2016, Armonk, NY) for all ana-
lyses. All variables were tested for normality before presenting data 
as either mean ± standard deviation (SD) or median (range), as ap-
propriate. For comparison of groups, standard paired T-test, Wil-
coxon signed rank test, or Pearson Chi-Square test was used as ap-
propriate. Correlations were tested by Pearson correlation coeffici-
ent. The upper limit of normal (ULN) value was defined as 
mean + 1.64 SD unless otherwise specified. P values  < 0.05 were 
considered significant.
Ethical aspects
The study was in accordance with the Declaration of Helsinki and 
approved by the Regional Committee on Medical and Health Re-
search Ethics.
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Results
A total of 176 subjects were included for final analyses (82 children 
aged 8–17 years [31 males; 37.8 %], 94 adults aged 25–70 years 
[46 males; 48.9 %]). Reasons for exclusion were steatosis on B-mo-
de ultrasound in adults (n = 6) and either failure to obtain valid mea-
surements (n = 3) or obesity (n = 2) in the case of children. Back-
ground characteristics are shown in ▶table 1.
Overall results
In the total population, the mean CAP was 208 ± 44.1 dB/m (range 
100–348).
CAP values increased with age. Dividing participants into child-
ren, young adults ( < 39.9 years), and adults (40–70 years), the 
mean values were 191, 210, and 232, respectively (p-values 0.018, 
0.018, and  < 0.001, respectively, for comparisons between conse-
cutive age groups). In linear regression, CAP was associated with 
age, BMI z-score, skin-to-capsule distance, and sex (p-values 0.049, 
0.011, 0.011, and 0.049, respectively) (▶Fig. 1). CAP was signifi-
cantly correlated with BMI z-score in children (rho 0.27, p = 0.014) 
and adults (rho 0.54, p < 0.001). This difference in the degree of 
correlation reflects a steeper rise in adults than children (▶Fig. 2). 
CAP values were not affected by LSM by either TE, 2D-SWE, or 
pSWE.
Regarding quality criteria, the overall CAP interquartile range 
(IQR) was 41 ± 23 (range 7–225). We found that 53 % of values were 
within the proposed quality criteria of IQR  < 40, while 19, 55 and 
81 % had an IQR/M value less than 0.1, 0.2, and 0.3, respectively. 
IQR exerted no effect on CAP value. IQR was not affected by CAP, 
LSM (or LSM IQR/M) by any system, sex, or age.
CAP in children
In children aged 8–17 years, the mean CAP was 191 ± 38 dB/m 
(range 100–296 dB/m), and 82 % and 94 % of subjects had CAP re-
sults within the normal range as defined by the published cutoff 
value  < 225 for children and  < 248 dB/m for adults, respectively. 
ULN calculation yielded a cutoff value of 253 dB/m. The only 
 significant factors affecting CAP in children were the BMI z-score 
(▶table 3) and waist circumference z-score (p-values 0.01 and 
0.011, respectively). The skin to capsule distance was not associa-
ted with CAP. The CAP value was found to rise with BMI z-score, 
start ing at a BMI z-score between –1 and 0 (▶Fig. 3). Using the 
pub lished  cutoff value of 225 dB/m, BMI z-scores were not signifi-
cantly higher in the high compared to the low CAP group (mean 
value  + 0.34 vs. –0.2 p = 0.051).
CAP IQR was 44.6 ± 20 (range 10–101). We found that 45 % had 
an IQR  < 40, while 9, 44 and 72 % had an IQR/M value less than 0.1, 
0.2, and 0.3, respectively.
Trying to establish an upper limit of normal (ULN) for these qua-
lity criteria in our presumably healthy, non-obese children using 
the lowest 90 % of values, the IQR and IQR/M cutoff values would 
be  < 69 and IQR/M  < 0.4, respectively.
▶table 1 Background characteristics of patients undergoing ultrasound elastography and controlled attenuation parameter (CAP) measurements.
total panel children Adults
Number 176 82 94
Males, number ( %) 77 (43.8) 31 (37.8) 46 (48.9)
Age, median (range) 26 (8–69) 13.3 (8.4–17.9) 42.5 (25–69)
Body mass index z-score, mean (SD) 0.2 (0.9) −0.1 (1.0) 0.4 (0.7)
Overweight subjects (IOTF = 1), n ( %) 35 (19.9) 5 (6.1) 30 (31.9)
Overweight subjects according to BMI z-score, n ( %) 22 (12.5) 6 (7.3) 16 (17)
Fib-4, n ( %)
 Low risk – 70 (74.5)
 Indeterminate – 24 (25.5)
 High risk – –
NAFLD fibrosis score, n ( %)
 Low risk – 94 (100)
 Indeterminate – –
 High risk – –
Fatty liver index, n ( %)
 Low risk – 77 (81.9)
 Indeterminate – 10 (10.6)
 High risk – 7 (7.4)
 *  TE  =  transient elastography; pSWE  =  point shear wave elastography; 2D-SWE  =  two-dimensional shear wave elastography; kPa  =  kilopascals; IOTF 
(International Obesity Task Force); Fib-4  =  Fibrosis-4 index; NAFLD  =  nonalcoholic fatty liver disease.
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CAP in adults
In adults, the mean CAP was 223 ± 44 dB/m (range 100–348), and 
56 % and 77 % of subjects had CAP results within the normal range 
as defined by the published cutoff value  < 225 for children 
and  < 248 dB/m for adults, respectively. ULN calculation yielded a 
cutoff value of 295 dB/m. CAP correlated with age, sex, BMI (▶Fig. 4), 
waist circumference, and skin to capsule distance (▶table 2). How-
ever, the skin-to-capsule distance was the only factor showing in-
dependent association to CAP in linear regression (p = 0.005).
The mean CAP values for men and women were 235 ± 45 and 
210 ± 40, respectively. Adults with CAP  > 248 dB/m had a signifi-
cantly higher BMI compared to those with a lower CAP (mean value 
25.8 vs. 23.1, p < 0.001).
CAP values were highly correlated with the fatty liver index (rho 
0.55, p < 0.001) (▶Figs. 5 and ▶6) and correlated with the NAFLD 
fibrosis score (rho 0.21, p = 0.046). CAP was not correlated with 
Fib-4 or ALT (▶table 2). The percentage of subjects with low, in-
determinate, or high-risk values for different indexes are shown in 
▶table 1, based on published values [16, 17, 19, 20].
Interquartile range (IQR) was 37.6 (25), with a range of 7–225. 
We found that 61 % had an IQR  < 40, while 28, 64, and 89 % had an 
IQR/M value less than 0.1, 0.2, and 0.3, respectively.


























Body mass index z-score
▶Fig. 2 Body mass index z-score versus controlled attenuation parameter for all participants, with children in blue and adults in red, with fit lines 
for both subgroups.
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Using the lowest 90 % of values to establish a ULN in adults, the 
IQR and IQR/M cutoff values would be  < 57 and  < 0.3, respectively.
Discussion
This is, to the best of our knowledge, the first study reporting CAP 
values in healthy non-obese children and adults of all ages. Previ-
ous studies in adults have shown that a raised CAP is often found 
in apparently healthy individuals without evident steatosis upon 
ultrasound examination [21]. Our study is the first to describe that 
CAP increases with increasing BMI z-score even in healthy subjects 
with a BMI z-score below zero (corresponding to a BMI  < 22 in 
adults). In line with our findings, an association between CAP and 
BMI has previously been shown in adults, with an estimated rise of 
4.4 dB/m per BMI unit. However, whether this is valid for the enti-
re BMI specter or only for a specific interval remains uncertain 
[9, 22]. In contrast, a biopsy-controlled study including children 
and young adults up to 24 years of age reported a higher BMI in 
subjects with steatosis than those without steatosis while display-
ing no significant association between BMI and CAP. All subjects 
with proven steatosis had a BMI z-score  > 1.0 [10].
▶Fig. 3 Body mass index z-score versus controlled attenuation parameter (CAP) for children aged 8–17 years. Rho 0.27 (p = 0.014). The vertical line 
(z-score –1) reflects where a rise in CAP values begins. Above the –1 reference line, there is a highly significant relationship between CAP and BMI 
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In children, we found that 18.3 % had a CAP above the sugges-
ted cutoff value of 225 dB/m. Only five children (6.1 %) were above 
the suggested adult cutoff value of 248 dB/m; all of them were nor-
mal weight, with BMI z-scores ranging from –1.7 to  + 1.2. In our 
study, all but one of the children with a CAP  > 248 dB/m had BMI 
z-scores  ≤ 1.0, suggesting that steatosis was less likely based on 
the aforementioned biopsy-controlled study [10]. NAFLD may 
occur in non-overweight individuals, so-called “lean” NAFLD. A study 
with 1482 adolescents (12–18 years) with a BMI below the 85th per-
centile (corresponding to a BMI z-score less than  + 1) found that 
8 % had suspected NAFLD, but with no difference in BMI z-score bet-
ween those with and without suspected NAFLD [3]. Similar or hig-
her incidence rates have been firmly established in lean adults, even 
in biopsy-proven studies [23–26]. To our knowledge, there are no 
reports specifically investigating CAP in individuals with a below-
average BMI.
The rise in CAP across BMI z-scores was steeper in adults than 
children. Given an identical increase in BMI in children and adults, 
adults showed a more substantial CAP increase (▶Fig. 2).
In adults, CAP was correlated with all anthropometric values in-
dicating obesity: BMI, waist circumference, and skin-to-capsule di-
stance (▶table 2). These parameters were highly correlated and 
challenging to use as independent variables. Interestingly, in linear 
regression, the only factor independently associated with CAP in 
adults was the skin-to-liver capsule distance, indicating that this 
measure of subcutaneous fat tissue is more closely associated with 
steatosis than BMI. BMI is considered a rather reliable predictor of 
body fat, but obesity may be either overestimated or underestima-
ted based on the amount of muscle tissue, and a high BMI does not 
necessarily indicate obesity or a high degree of body fat [27]. How-
ever, although easy to obtain, skin-to-capsule distance requires ul-
trasound, making BMI more available for clinicians without ultra-
sound access.
Our finding of a high degree of correlation between CAP and the 
fatty liver index confirms previous results [28]. There was a small 
but significant correlation with NAFLD fibrosis score and no corre-
lation with Fib-4. There are several reasons why it is difficult to com-
pare a new parameter with these index scores: Both Fib-4 and the 
NAFLD fibrosis score have been shown to have unacceptable diag-
nostic accuracy among non-obese individuals as well as in subjects 
aged  ≤ 35 or  > 65 years, making them difficult to interpret in our 
material [29, 30]. That being said, they both perform best when 
used to rule out, not rule in, advanced fibrosis, and none of our sub-
jects were above the upper cutoff value, where an excellent speci-
ficity has been demonstrated [31].
▶table 2 Correlation between CAP and clinical features and labora-
tory values for adults.
clinical features correlation (r) p-value
Distance from skin to liver capsule 0.615  < 0.001
BMI 0.574  < 0.001
Waist circumference 0.572  < 0.001
Weight 0.536  < 0.001
Waist-to-height ratio 0.487  < 0.001
Fatty liver index 0.545  < 0.001
GGT 0.324 0.001
Triglycerides 0.298 0.003
LDL 0.270  < 0.001
Cholesterol 0.216  < 0.001
HDL −0.219 0.034
NAFLD fibrosis score 0.207 0.046
ALT 0.173 n.s.
FIB-4 0.011 n.s.
BMI: body mass index; GGT: gamma-glutamyl transferase; NAFLD: 
non-alcoholic fatty liver index; ALT: alanine transaminase; FIB-4: 
Fibrosis-4; HDL: high-density lipoprotein; LDL: low-density 
lipoprotein.
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CAP correlated with age in adults but not in children. In linear re-
gression, we found that the increasing CAP values during adulthood 
only reflected the increasing prevalence of obesity with age. CAP va-
lues were higher in adults than in children. This difference persisted 
after correction for the increased BMI in adulthood, suggesting that 
CAP increase may be a phenomenon linked to the transition into 
adulthood, as there was no significant effect of age within the two 
individual cohorts. This is in contrast to liver stiffness measurements, 
where an age effect is often found in children [15].
The use of quality criteria is heavily advocated in liver stiffness 
measurements, particularly the use of IQR/M. There is no consen-
sus on the use of similar criteria in CAP measurements. However, 
it was reported that IQR seems to be independent of CAP values 
and that an IQR  < 40 increases the diagnostic accuracy of CAP [12]. 
Other authors have not been able to reproduce this while arguing 
that a low IQR/M for CAP significantly increases the accuracy of di-
agnosing steatosis [13], with several suggested cutoff valu-
es:  < 0.1,  < 0.2, and  < 0.3.
In our study, we observe that a substantial number of subjects 
do not meet the proposed quality criteria, with an IQR  < 40 in 45 % 
and 61 %, and an IQR/M  < 0.1 in 9 % and 28 %, in children and adults, 
respectively.
Our findings support a lack of correlation between CAP and IQR 
value, meaning that measurement variation is similar for a range 
of CAP values. Thus, with a stable IQR value across CAP values, the 
IQR/M will decrease when the CAP increases. In our cohort of 
healthy individuals, it is impossible to evaluate the effect of IQR or 
IQR/M on diagnostic accuracy.
Although already obviously useful, CAP will hopefully continue 
to improve, with promising modifications, such as continuous CAP, 
in the pipeline [32].
Limitations
The major limitation is the lack of liver biopsies or magnetic reso-
nance imaging-based fat fraction quantification (MRI-PDFF), ma-
king us unable to rule out liver steatosis with certainty. We tried to 
combat this by excluding obese individuals and performing B-mo-
de ultrasound to rule out increased liver echogenicity. We perfor-
med blood tests to exclude other liver diseases in adults, but it was 
deemed unethical in healthy children.
Conclusion
CAP is highly correlated to BMI z-score across all ages, even in sub-
jects with a BMI below average (z-score  < 0). Skin-to-capsule dis-
tance in adults is a stronger predictor of increased CAP compared 
to BMI. Approximately 1 in 5 healthy, non-obese subjects had a CAP 
value above the suggested cutoffs for liver steatosis, warranting 
further research to clarify whether this should lead to an adjust-
ment of reference values. Using our results, CAP ULN would be in-
creased from 225 and 248 to 253 and 295 in children and adults, 
respectively.
▶Fig. 6 Controlled attenuation parameter (CAP) for low, moderate, and high fatty liver index (FLI). FLI:  < 30 (ruled out); 30–59 (indetermina-














▶table 3 Correlation between CAP and clinical features for children.
clinical features correlation (r) p-value
Waist-to-height ratio 0.292 0.008
BMI z-score 0.271 0.014
Waist circumference z-score 0.116 n.s.
Skin-to-capsule distance 0.057 n.s.
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